This fall, the Centers for Disease Control and Prevention, Atlanta, selected the Interstitial Cystitis Association as its partner to manage and direct a 5-year campaign to increase awareness of interstitial cystitis among health care providers and patients.
This fall, the Centers for Disease Control and Prevention, Atlanta, selected the Interstitial Cystitis Association as its partner to manage and direct a 5-year campaign to increase awareness of interstitial cystitis among health care providers and patients. The multi-faceted National IC Awareness and Education Campaign will employ creative communication strategies to educate patients about asking the right questions and seeking the most appropriate treatment. The initiative will also encourage health care providers to better diagnose and treat IC.
EV/pembrolizumab under review in China for advanced urothelial carcinoma
March 28th 2024The sBLA is supported by findings from the phase 3 EV-302 trial, which showed that EV/pembrolizumab extended overall survival and progression-free survival vs platinum-based chemotherapy in patients with advanced urothelial carcinoma.
Potential code for prior authorizations on AMA CPT Editorial Panel meeting agenda
March 28th 2024"Good public and economic policy must align costs, benefits, and incentives; currently, all costs are incurred by physician practices, and all financial savings and benefits from prior authorization accrue to health insurance plans, leading to perverse incentives,” says Alex Shteynshlyuger, MD.